India Globalization Capital, Inc. (NYSE: IGC) Pioneering New Phytocannabinoid Products

India Globalization Capital, Inc. (NYSE: IGC) Pioneering New Phytocannabinoid Products
India Globalization Capital, Inc. (NYSE: IGC) Pioneering New Phytocannabinoid Products
by is licensed under

Although legal in 28 states for medicinal use, cannabis is still considered a dangerous substance in much of the country. However, many experts now believe that cannabis is a safe alternative to pharmaceuticals for relieving symptoms related to multiple illnesses. Scientific research shows that phytocannabinoids, cannabinoids that occur naturally in the cannabis plant, are effective at relieving convulsions, seizures, anxiety, nausea, and inflammation. From fighting glaucoma to controlling epileptic seizures and easing pain, scientific research has repeatedly shown the efficacy of medicinal marijuana.

Due to government misclassification of cannabis as a Schedule 1 drug, there has been only marginal progress in the utilization of phytocannabinoids, which hold such promise in disease treatment and pain mitigation. Although many pharmaceutical companies still avoid association with cannabinoids, attitudes are changing, and the medicinal benefits of marijuana are being recognized for their worth.

Read the full article

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer 


Tags
Cannabis Focus, Cannabis Industry, Health
Thumbnail Photo Credit: by is licensed under